Latest News
FDA/CDC
FDA approves Sympazan for Lennox-Gastaut syndrome
Patients with Lennox-Gastaut syndrome can have difficulty swallowing pills or large-volume oral suspensions, so this oral film may reduce care...
Feature
Heart drug spotlights troubling trends in drug marketing
Critics worry the marketing of Vascepa, a purified fish-oil product, could prove a fish story.
Conference Coverage
Sleep: The new frontier in cardiovascular prevention
MUNICH - Sleep that’s too little, too much, or too disrupted boosts cardiovascular risk.
Conference Coverage
Opioids negatively affect breathing during sleep
Long-term use of opioids, including methadone therapy, increases the risk of central sleep apnea, though adaptive servo ventilation can...
From the Journals
Exercise improves outcomes for patients with heart failure and OSA
Exercise alone or in addition to CPAP significantly improves quality of life for patients with heart failure and obstructive sleep apnea.
Feature
CMS delays controversial E/M changes in final rule
CMS has delayed its proposed collapsing of E/M codes, while reducing documentation requirements for health providers in its 2019 fee schedule.
FDA/CDC
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
News
Appendix linked to Parkinson’s disease in series of unexpected findings
Appendectomy reduces PD risk by about 20%.
Latest News
Funding for NIH BRAIN Initiative reaches new heights
Latest News
The election’s impact on health care: Some bellwether races to watch
Here are three big health issues that could be dramatically affected by Tuesday’s vote.
Conference Coverage
CT opens extended window for stroke thrombolysis
MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.